Fedha

Beta
Hisa unazofuatilia
Sekta za hisa
Alama
Alama
Bei
Tofauti
Tofauti ya asilimia
Mwenendo wa data
Bei ya Awali
Fungua
Juu
Chini
Kiasi cha mauzo ya hisa
Mtaji wa Soko
SIXB
Materials
SIXB
Materials
SIXB
+0.99%
1,093.81
+10.77
+0.99%
—1,083.041,082.631,099.011,080.59——
SIXC
Communications
SIXC
Communications
SIXC
+1.06%
608.77
+6.39
+1.06%
—602.38602.38609.75599.75——
SIXE
Energy
SIXE
Energy
SIXE
+0.96%
1,254.81
+11.98
+0.96%
—1,242.831,229.311,258.881,220.51——
SIXI
Industrials
SIXI
Industrials
SIXI
+2.76%
1,761.11
+47.29
+2.76%
—1,713.821,715.471,763.111,715.47——
SIXM
Financials
SIXM
Financials
SIXM
+0.40%
642.58
+2.59
+0.40%
—639.99636.98644.04631.81——
SIXR
Staples
SIXR
Staples
SIXR
+1.63%
851.13
+13.67
+1.63%
—837.46840.30852.55840.30——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.76%
217.98
+3.76
+1.76%
—214.22214.22218.25214.05——
SIXT
Technology
SIXT
Technology
SIXT
+0.23%
3,211.83
+7.45
+0.23%
—3,204.383,215.043,217.443,159.90——
SIXU
Utilities
SIXU
Utilities
SIXU
+2.55%
948.98
+23.60
+2.55%
—925.38927.91949.76927.91——
SIXV
Health care
SIXV
Health care
SIXV
+2.20%
1,474.52
+31.81
+2.20%
—1,442.711,443.011,477.901,443.01——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+1.30%
2,392.12
+30.78
+1.30%
—2,361.342,391.002,399.182,354.52——
Mapato ya Q1 2026 • baada ya siku 4
Angalia maelezo
BMRN:NASDAQ
Biomarin Pharmaceutical Inc
US$ 53.91
-0.55%
(-0.30) Siku 1
US$ 53.92
+0.02% (+0.0100)
Baada ya saa
Imefungwa: 30 Apr, 16:00:01 GMT -4  ·   USD
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya BMRN...
Fungua
US$ 54.01
Juu
US$ 54.88
Chini
US$ 53.76
Mtaji wa soko
10.42B
Wastani wa kiasi cha mauzo
1.83M
Kiasi cha mauzo ya hisa
1.59M
Uwiano wa bei ya hisa na mapato kwa kila hisa
29.87
Juu kwa wiki 52
US$ 66.28
Chini kwa wiki 52
US$ 50.76
EPS
US$ 1.80
Beta
0.29
Hisa za wawekezaji
192.32M
Idadi ya wafanyakazi
elfu 3
Habari
Kutoka kwenye vyanzo vya wavuti
Wasifu
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies. BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria. Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials. Wikipedia
Kuhusu Biomarin Pharmaceutical Inc
Afisa Mkuu Mtendaji (CEO)Alexander Hardy
Wafanyakazielfu 3.22
LilianzishwaMac 1997
Makao makuuSan Rafael, California, Marekani
Sekta-
Tovutibiomarin.com
Simu inayofuata baada ya siku baada ya siku 4
Jumatatu, 4 Mei, 16:30
Kipindi cha Kifedha
Robo1 2026
Mapato Yaliyosawazishwa kwa Kila Hisa au Kadirio
-/ (0.93 inakadiriwa)USD
Mapato au Kadirio
-/ (751.68M inakadiriwa)USD
Mkutano pepe wa kujadili mapato ya robo ya Robo ya 1 ya mwaka wa fedha wa 2026
Inasubiri mkutano pepe wa kujadili mapato
Kwa muhtasari: mapato yajayoMaarifa kutoka kwenye ripoti na habari za hivi punde
Ripoti za awaliThamani zote katika USD
Loading Previous Earnings...
Taarifa ya mapato
Mapato
Mapato halisi
Thamani zote katika USD
Mac 2025
Jun 2025
Sep 2025
Des 2025
Mapato
745.14M
825.41M
776.13M
874.56M
Gharama ya bidhaa zilizouzwa
310.29M
311.40M
549.56M
348.91M
Gharama ya mapato
310.29M
311.40M
549.56M
348.91M
Gharama za utafiti na maendeleo
-
-
-
-
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
206.12M
232.28M
268.42M
324.16M
Gharama ya uendeshaji
210.96M
237.12M
273.26M
329.01M
Jumla ya gharama za uendeshaji
521.25M
548.52M
822.82M
677.92M
Mapato ya uendeshaji
223.89M
276.89M
-46.69M
196.64M
Mapato mengine yasiyo ya uendeshaji
-1.95M
4.83M
5.09M
1.02M
EBT ikijumuisha vipengee visivyo vya kawaida
238.09M
297.87M
-26.32M
-27.15M
EBT bila kujumuisha vipengee visivyo vya kawaida
238.09M
297.87M
-26.32M
214.10M
Gharama ya kodi ya mapato
52.40M
57.34M
4.42M
19.42M
Kiwango cha kodi kinachotumika
22.01%
19.25%
-16.79%
-71.52%
Gharama nyingine za uendeshaji
-
-
-
-
Mapato halisi
185.69M
240.53M
-30.74M
-46.57M
Kiwango cha faida halisi
24.92%
29.14%
-3.96%
-5.33%
Mapato kwa kila hisa
1.13
1.44
0.12
0.46
Mapato ya riba na uwekezaji
19.01M
18.83M
17.85M
19.21M
Gharama ya riba
-2.86M
-2.68M
-2.58M
-2.78M
Jumla ya gharama halisi za riba
16.15M
16.15M
15.28M
16.43M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
245.96M
295.45M
-28.20M
209.68M
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho

Utafiti

Majukumu yangu
Bado hujaanzisha jukumu lolote
Majukumu yako yataonekana hapa. Ratibu majukumu na uruhusu Google Finance ifanye kazi ukiwa mbali.
Violezo
Muhtasari wa hisa unazofuatilia
Uchanganuzi wa kila siku wa kabla ya soko kufunguliwa wa orodha ya hisa unazofuatilia
Mapato Yajayo
Ripoti za mapato yajayo katika wiki
Mabadiliko ya Bei na Kiasi cha Hisa Kisicho cha Kawaida
Onyo la mapema kuhusu mabadiliko ya kiwango cha miamala leo
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho